Company Description
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.
The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product.
It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions.
In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions.
electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
| Country | United States |
| Founded | 2005 |
| IPO Date | Jun 22, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 83 |
| CEO | Daniel Goldberger |
Contact Details
Address: 200 Forge Way, Suite 205 Rockaway, New Jersey 07866 United States | |
| Phone | 888 903 2673 |
| Website | electrocore.com |
Stock Details
| Ticker Symbol | ECOR |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001560258 |
| CUSIP Number | 28531P103 |
| ISIN Number | US28531P2020 |
| Employer ID | 20-3454976 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Thomas J. Errico M.D. | Founder and Independent Chairman |
| Joshua S. Lev | Chief Financial Officer and Interim President |
| Donald Melnikoff | Senior Vice President of Engineering, Regulatory and Compliance |
| Mitch Deshon | Vice President of Global Sales and Business Development |
| Jennifer A. Hayes | Vice President of Human Resources and Employee Success |
| Dr. Peter S. Staats M.B.A., M.D. | Chief Medical Officer |
| Amanda Yanuklis | Chief of Staff |
| Andy Brown | Vice President and Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2026 | 144 | Filing |
| Apr 15, 2026 | D | Notice of Exempt Offering of Securities |
| Mar 19, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 19, 2026 | 10-K | Annual Report |
| Mar 19, 2026 | 8-K | Current Report |
| Jan 20, 2026 | 8-K | Current Report |
| Nov 13, 2025 | SCHEDULE 13G/A | Filing |
| Nov 5, 2025 | 10-Q | Quarterly Report |
| Nov 5, 2025 | 8-K | Current Report |
| Oct 24, 2025 | 424B3 | Prospectus |